Autopsy report · NCT02644486

A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy

“difficulty in enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 1 month before it stopped.
• 4 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Zhi-Hong Liu, M.D.

Sponsor type

University, hospital or other

Conditions

Obesity and Glomerulopathy

Interventions

High dosage Sevelamer Carbonate + Irbesartan; Low dosage Sevelamer Carbonate + Irbesartan; Irbesartan

Participants

4

Sites

1

Countries

China

Trials that died the same way

• Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease
  “Difficulty with enrollment” (98% match in meaning)
• Maintenance Dosing of Vitamin D in Crohn's Disease
  “Difficulties with enrollment” (97% match in meaning)
• AVAD: Asthma With Small Airways Dysfunction
  “difficulties of enrollment” (96% match in meaning)
• Tiotropium vs. Inhaled Corticosteroids in Children With Nonatopic Asthma Pilot Study (TioNAAP)
  “Difficult enrollment” (95% match in meaning)
• Clinical Trial With Mesalamine 1g Suppositories
  “Enrollment difficulties” (95% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.